How would you treat a relatively focal but multinodular staple line recurrence of non-mutated lung adenocarcinoma s/p margin-negative lobectomy?   

E.g. Recurrent one year out from neoadjuvant chemo-immunotherapy and margin-negative lobectomy. SBRT vs. larger-field chemoRT? Difference in approach for central lesions abutting multiple structures? 



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Cleveland Clinic
I agree 100%. Here is a second reference written b...
Sign in or Register to read more